Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Name: Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Published: 2026
License: Public Domain

Athos Therapeutics Inc · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

autoimmune-diseases ibd inflammatory-bowel-diseases ulcerative-colitis

ulcerative colitis, inflammatory bowel diseases, autoimmune diseases, colitis, ulcerative, ibd, biologic refractory, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Related documents